[Role of cyclo-oxygenases in the effects of angiotensin II].
Wu
Rong
R
Département de physiologie, Université de Montréal, CP 6128-Succursale Centre-Ville, Québec, Canada.
Laplante
Marc-André
MA
de Champlain
Jacques
J
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000503:physiopathology; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D006801:Humans; D007783:Lactones / Q000494:pharmacology; D008954:Models, Biological; D018384:Oxidative Stress; D013450:Sulfones / Q000494:pharmacology
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib; D000804:Angiotensin II; D001241:Aspirin